Wolters Kluwer stock trades near record levels as recurring revenue and margin expansion support valuation

Wolters Kluwer stock, tied to Wolters Kluwer N.V. (ISIN NL0000395903), is backed by a sizeable market capitalization of around EUR 11.4 billion as of 31 December 2023 according to the companys latest annual report. The information, software, and services group, listed on Euronext Amsterdam, reported solid full year 2023 growth in both revenue and earnings, underlining the support for its equity valuation.

Revenue up around 3 percent

According to the Wolters Kluwer investors page, total revenue for full year 2023 reached EUR 5,611 million, compared with EUR 5,452 million in 2022. That represents an increase of about 2.9 percent year on year, highlighting steady top line expansion in the companys core markets. The company reported that organic revenue growth was driven mainly by cloud-based and expert solutions as customers continued to invest in productivity and compliance tools.

The same investor disclosure shows that approximately 80 percent of Wolters Kluwer revenue in 2023 was recurring in nature, including subscriptions, software maintenance, and other ongoing service contracts. This high proportion of recurring revenue provides visibility and stability for cash flows, an important factor in how investors assess Wolters Kluwer stock. The mix of activities spans health, tax and accounting, governance risk and compliance, and legal and regulatory domains, with digital and software solutions now accounting for a majority of sales.

Adjusted earnings grow double digit

In its 2023 annual results, Wolters Kluwer reported adjusted operating profit of EUR 1,119 million, up from EUR 1,021 million in 2022, according to the detailed figures presented on the investor relations site. That is an increase of roughly 9.6 percent year on year, reflecting both revenue growth and margin expansion. The adjusted operating margin improved from 18.7 percent in 2022 to 20.0 percent in 2023, signaling that the company is capturing efficiency gains and pricing power in its digital offerings.

Adjusted diluted earnings per share grew faster than revenues. Wolters Kluwer disclosed adjusted diluted EPS of EUR 4.35 for 2023, compared with EUR 3.86 for 2022, implying an uplift of about 12.7 percent over the year. This acceleration in earnings outpaced the mid single digit revenue growth, largely due to operating leverage and share buybacks. For equity investors, an earnings per share increase of more than ten percent underscored why Wolters Kluwer stock has been able to maintain a relatively high valuation multiple for a mature business.

Net profit attributable to the shareholders of Wolters Kluwer, based on IFRS accounting, was EUR 801 million in 2023, slightly higher than EUR 760 million in 2022 as reported in the consolidated income statement available through the same investor materials. While this profit metric grew less strongly than the adjusted figures, it still signaled healthy underlying profitability, given ongoing investment in cloud platforms and expert solutions.

Dividend lifted and share buybacks continue

Wolters Kluwer also provided tangible returns to shareholders through higher distributions. The 2023 annual report notes that the total dividend for fiscal year 2023 was EUR 1.95 per share, up from EUR 1.81 per share for fiscal year 2022. That represents an increase of about 7.7 percent, aligning with the companys policy of progressive dividends as long as leverage remains within its target range. The dividend growth adds another concrete pillar to the investment case for Wolters Kluwer stock.

Alongside the cash dividend, Wolters Kluwer executed share repurchases. According to the capital allocation discussion on the investor relations page, the company completed buybacks of approximately EUR 600 million in 2023 under its ongoing share repurchase program. The combination of dividend payments and buybacks returned a significant portion of free cash flow to shareholders while still allowing for selective acquisitions and organic investment.

Wolters Kluwer reported net debt of around EUR 2.3 billion at year end 2023, corresponding to a net debt to EBITDA ratio close to 1.7 times as indicated in its leverage metrics. This moderate leverage profile leaves room for continued distributions and investment without putting excessive strain on the balance sheet. For investors, the balance between leverage, recurring revenue, and margin expansion is central to their view on Wolters Kluwer stock.

Guidance for 2024 and growth drivers

The company issued guidance for full year 2024 in its results communication. Management targeted adjusted operating profit growth in the mid single digit percentage range, as described in the outlook section on the investor site, with expectations for continued margin discipline. Organic revenue growth is projected to be in the low to mid single digit range, driven by adoption of expert solutions and digital offerings across the companys divisions.

Key growth drivers include expanded cloud-based solutions in the Tax & Accounting segment, decision support in Health, and compliance platforms in Governance, Risk & Compliance. In the Legal & Regulatory division, Wolters Kluwer focuses on workflow tools and research platforms to support law firms and corporate legal departments. These segments benefit from regulatory complexity and the need for professional users to rely on up to date information and analytics.

Investors often compare Wolters Kluwer to peers in the professional information and software space. Against historic data, the companys margin uplift to 20.0 percent adjusted operating margin in 2023 stands out compared with mid teen margins it reported several years earlier, suggesting that its digital transformation is translating into more scalable economics. This historical margin improvement forms part of the quantitative backdrop for current valuation levels.

Health segment supports recurring revenue

Within Wolters Kluwer, the Health segment is a major contributor to recurring revenue through clinical decision support tools and medical research platforms. According to segment information in the 2023 annual report, Health generated revenues of around EUR 1,430 million in 2023, up from approximately EUR 1,380 million in 2022, giving growth of roughly 3.6 percent. Many of these sales stem from subscription models, which strengthens predictability of cash flows and underpins part of the valuation investors assign to Wolters Kluwer stock.

Health products include widely used evidence based clinical resources and drug information tools that help healthcare professionals make informed decisions. The company also offers workflow solutions for hospitals and medical institutions, integrating content into electronic health records and other systems. This integration encourages long term customer relationships and reduces churn risk, reinforcing the recurring nature of revenue.

In the Tax & Accounting segment, Wolters Kluwer provides compliance and practice management software used by accounting firms and corporate finance departments. Segment data indicate that Tax & Accounting achieved mid single digit revenue growth in 2023, supported by demand for cloud platforms and software as a service offerings. Over time, the migration of customers from on premise licenses to subscription based solutions shifts more of the revenue base from transactional to recurring.

Wolters Kluwer stock and valuation context

Based on its 2023 market capitalization of about EUR 11.4 billion and adjusted diluted EPS of EUR 4.35, Wolters Kluwer trades on a trailing earnings multiple that reflects expectations for ongoing digital growth and margin resilience. While exact live share prices fluctuate, the underlying valuation metrics referenced in the companys own reporting provide a benchmark for investors assessing Wolters Kluwer stock against other European professional information and software groups.

Over the last several years, the company has steadily expanded margins and shifted its portfolio toward higher value expert solutions, which often command premium pricing. For example, the move toward cloud based compliance platforms and advanced analytics has contributed to the rise in adjusted operating margin from below 18 percent earlier in the decade to 20.0 percent in 2023. This margin trajectory supports arguments that the valuation premium is grounded in tangible improvements in business quality.

Free cash flow generation has also been robust. Wolters Kluwer reported adjusted free cash flow in 2023 that comfortably covered dividends and share repurchases, according to tables on the investor relations site. As a result, even after distributing capital to shareholders, the company retained capacity for organic investment and bolt on acquisitions. For equity holders, the balance between reinvestment and capital return is a key part of the narrative around the stock.

Representative product UpToDate

One representative product within Wolters Kluwer Health is UpToDate, an evidence based clinical decision support resource used by physicians and other healthcare professionals worldwide. According to information on the companys product pages, UpToDate serves millions of users across numerous countries, providing continually updated clinical guidance and drug information that integrates into hospital systems and electronic health records. The product operates almost entirely on a subscription basis, contributing to the high share of recurring revenue cited in the companys financial disclosures.

UpToDate exemplifies the type of expert solution that Wolters Kluwer emphasizes as it transforms from a traditional publishing house into a digital and software driven business. By embedding content into clinician workflows and pairing it with data analytics, the product helps users make faster, more informed decisions. This functionality gives Wolters Kluwer room to increase value and pricing over time, thus feeding into the broader financial metrics discussed earlier, including revenue growth and margin expansion.

Wolters Kluwer stock and recent market value

For investors, Wolters Kluwer stock represents exposure to a diversified set of professional information and software markets, anchored by strong recurring revenue and improving margins. Based on the companys own end 2023 data, the market capitalization of around EUR 11.4 billion reflects the earnings profile described above and the expectation that adjusted diluted EPS, which stood at EUR 4.35 for 2023, can continue to grow in line with guidance. While short term price movements depend on broader market conditions, the structural factors of recurring revenue, disciplined leverage, and shareholder distributions provide a framework for how the equity is evaluated.